116 related articles for article (PubMed ID: 22029190)
21. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
22. Low high-density lipoprotein cholesterol is not responsible for decreased paraoxonase activity in chronic renal failure.
Varga É; Seres I; Harangi M; Kárpáti I; Koncsos P; Sztanek F; Paragh G
Kidney Blood Press Res; 2012; 35(4):265-72. PubMed ID: 22378349
[TBL] [Abstract][Full Text] [Related]
23. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
24. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
[TBL] [Abstract][Full Text] [Related]
25. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
26. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
[TBL] [Abstract][Full Text] [Related]
27. Assessment of xanthine oxidase in human lung and lung transplantation.
Kinnula VL; Sarnesto A; Heikkilä L; Toivonen H; Mattila S; Raivio KO
Eur Respir J; 1997 Mar; 10(3):676-80. PubMed ID: 9073004
[TBL] [Abstract][Full Text] [Related]
28. Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation.
Krzystek-Korpacka M; Boehm D; Matusiewicz M; Diakowska D; Grabowski K; Gamian A
Clin Biochem; 2008 Jul; 41(10-11):804-11. PubMed ID: 18423402
[TBL] [Abstract][Full Text] [Related]
29. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
30. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
31. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
[TBL] [Abstract][Full Text] [Related]
32. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study.
Juretić D; Tadijanović M; Rekić B; Simeon-Rudolf V; Reiner E; Baricić M
Croat Med J; 2001 Apr; 42(2):146-50. PubMed ID: 11259735
[TBL] [Abstract][Full Text] [Related]
33. Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS?
Dursun P; Demirtaş E; Bayrak A; Yarali H
Hum Reprod; 2006 Jan; 21(1):104-8. PubMed ID: 16155079
[TBL] [Abstract][Full Text] [Related]
34. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
Viktorinova A; Svitekova K; Stecova A; Krizko M
Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
[TBL] [Abstract][Full Text] [Related]
35. Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Hashim Z; Zarina S
Clin Biochem; 2007 Jun; 40(9-10):705-9. PubMed ID: 17466963
[TBL] [Abstract][Full Text] [Related]
36. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
37. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.
Kim NS; Kang K; Cha MH; Kang BJ; Moon J; Kang BK; Yu BC; Kim YS; Choi SM; Bang OS
Biochem Biophys Res Commun; 2007 Dec; 364(1):157-62. PubMed ID: 17936248
[TBL] [Abstract][Full Text] [Related]
38. 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer.
Oztürk O; Kağnici OF; Oztürk T; Durak H; Tüzüner BM; Kisakesen HI; Cakalir C; Isbir T
Anticancer Res; 2009 Oct; 29(10):4041-6. PubMed ID: 19846948
[TBL] [Abstract][Full Text] [Related]
39. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
